Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.64 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.62 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.62 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29539688 | 1.00 | LOXL2 (0.64) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL7276383 | 0.85 | LOXL2 (0.66) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL1198816 | 0.84 | CYP4F2 (0.61) | LOXL2CYP4F2CYP4A11ALDH1A1SMN1; SMN2 | |
| SCHEMBL2849191 | 0.84 | CYP4F2 (0.68) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL14049769 | 0.84 | NAMPT (0.52) | LOXL2CYP4F2CYP4A11ALDH1A1SMN1; SMN2 | |
| SCHEMBL28857189 | 0.84 | ENPP2 (0.46) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL21936783 | 0.84 | LOXL2 (0.64) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL2932991 | 0.83 | SLC7A5 (0.58) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 | |
| SCHEMBL13898526 | 0.83 | CA12 (0.47) | LOXL2CYP4F2CYP4A11SLC7A5ALDH1A1 | |
| SCHEMBL935888 | 0.83 | CA12 (0.47) | LOXL2CYP4F2CYP4A11SLC7A5MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119306629-A | Preparation method of m-cyanomethyl benzoate | 甘肃汉隆化工有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-221674259-U | Reaction kettle for preparing m-cyanomethyl benzoate | 云南衡楚药业有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-116143656-A | Preparation method of m-cyano methyl benzoate | 湖北仙盛科技股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-116037038-A | Reaction kettle for preparing m-cyanomethyl benzoate | 安庆市鑫琪精细化工有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-114805120-A | Synthesis process of m-cyanomethyl benzoate | 江苏瑞达环保科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-212092223-U | Reation kettle is used in preparation of metacyanomethyl benzoic acid methyl ester | 上海微巨实业有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-111777528-A | Preparation method of m-cyanomethyl benzoate | 湖北仙盛科技股份有限公司 | 2020-10-16 | — | — | CN | claimed |
| CN-111675631-A | Synthesis process of cyano ketoprofen | 湖北仙盛科技股份有限公司 | 2020-09-18 | — | — | CN | claimed |
| EP-0525506-B2 | A process for the alpha-monoalkylation of arylacetonitriles, arylacetoesters and arylacetic acids | TESSENDERLO CHEM NV (BE) | 1999-03-17 | — | — | EP | claimed |
| EP-0525506-A2 | A process for the alpha-monoalkylation of arylacetonitriles, arylacetoesters and arylacetic acids | TESSENDERLO CHEMIE N.V. (BE) | 1993-02-03 | — | — | EP | claimed |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4663630-A1 | NOVEL BENZIMIDAZOLONE DERIVATIVE COMPOUND AS AUTOTAXIN INHIBITOR | LG Chem, Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-20250332137-A1 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | MILESTONE PHARMACEUTICALS INC (CA) | 2025-10-30 | — | — | US | disclosed |
| US-20250195462-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | MILESTONE PHARMACEUTICALS INC (CA) | 2025-06-19 | — | — | US | disclosed |
| WO-1996030329-A1 | SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INCORPORATED (US) | 1996-10-03 | — | — | WO | disclosed |
| US-5523302-A | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-06-04 | — | — | US | disclosed |
| US-5278333-A | Heat treatment | TESSENDERLO CHEMIE N.V. (BE) | 1994-01-11 | — | — | US | disclosed |
| EP-0525506-A2 | A process for the alpha-monoalkylation of arylacetonitriles, arylacetoesters and arylacetic acids | TESSENDERLO CHEMIE N.V. (BE) | 1993-02-03 | — | — | EP | disclosed |
| US-4568377-A | IMPROVED CROP SAFETY | CHEVRON RESEARCH COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | ROCK1, ROCK2, RHOA | LOXL2 1086/4885CYP4F2 1873/4885CYP4A11 452/4885 |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | LOXL2 2908/4885CYP4F2 940/4885CYP4A11 361/4885 |
| US-20250332137-A1 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | TRPV1, KCNN1, KCNN3 | LOXL2 3808/4885CYP4F2 3647/4885CYP4A11 1819/4885 |
| US-20250195462-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | ORAI1, ATP2A1, RYR2 | LOXL2 3496/4885CYP4F2 3383/4885CYP4A11 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.